Latest 10-K annual reports
NYSE
Brookfield Oaktree Holdings, LLC reports its annual financial results for 2025, highlighting significant restructuring impacts, AUM growth, and a pending full acquisition by Brookfield.
SUPA Consolidated Inc. reports a significant working capital deficit and no revenue in its 2025 annual filing, raising substantial doubt about its ability to continue as a going concern despite a strategic pivot to food technology.
NASDAQ
ITHAX Acquisition Corp III's 10-K filing outlines its blank check company structure, financial position, and extensive risks as it seeks a business combination.
OTC.Pink
Bright Mountain Media reported a reduced net loss and increased revenue in 2025, but faces substantial doubt about its ability to continue as a going concern due to significant debt obligations and a worsening working capital deficit.
NASDAQ
ABSI
Absci CORPAbsci Corporation reported a wider net loss and decreased revenue for 2025, while advancing its lead antibody therapeutic, ABS-201, into clinical trials for androgenetic alopecia and endometriosis.
NASDAQ
BTC Development Corp., a SPAC focused on the bitcoin ecosystem, reported a net income of $1.87 million for the year ended December 31, 2025, primarily from trust account interest, as it continues its search for a business combination.
NASDAQ
Willamette Valley Vineyards, Inc. reported a significant increase in net loss to $917,685 for fiscal year 2025, driven by a 6.5% decrease in net sales revenue and higher selling expenses, despite a legal settlement gain.
NASDAQ
Andretti Acquisition Corp. II announced the termination of its business combination agreement with StoreDot and faces substantial doubt about its ability to continue as a going concern without securing a new acquisition.
NASDAQ
G-III Apparel Group reported a significant decrease in net sales and operating profit for fiscal year 2026, impacted by license expirations and asset impairments.
NYSE ARCA
Grayscale Sui Staking ETF reports a net decrease in assets for 2025 amid SUI price depreciation, while successfully uplisting to NYSE Arca and commencing a redemption program.
Blaize Holdings, Inc. reported a net loss of $206.9 million for 2025, a significant increase from the prior year, raising substantial doubt about its ability to continue as a going concern.
NYSE
MVO
Mv Oil TrustMV Oil Trust reports significant declines in income and distributions as its net profits interest is set to terminate on June 30, 2026, leading to the Trust's dissolution.
NYSE
VOC Energy Trust reported a significant decrease in net profits interest income and distributable cash for 2025, driven by lower oil prices and reduced sales volumes.
Strategic Storage Trust VI, Inc. reported a net loss of $36.6 million for 2025, driven by ongoing growth and lease-up activities, while maintaining a stable estimated net asset value of $10.00 per share.
NASDAQ
Biomea Fusion, a clinical-stage biopharmaceutical company, reported a reduced net loss in 2025 but faces substantial doubt about its ability to continue as a going concern, while strategically focusing on diabetes and obesity treatments.
OID
ECA Marcellus Trust I's 2025 annual report shows a significant increase in distributable income driven by higher natural gas prices, despite a decline in production volumes.
NASDAQ
LENZ Therapeutics commercially launched VIZZ, its FDA-approved presbyopia eye drop, in the U.S. in August 2025, generating initial product sales while continuing to incur significant net losses.
NASDAQ
VirnetX Holding Corporation reported a net loss of $18.2 million for 2025, despite increased revenue from a DoD subcontract and ongoing development of its cybersecurity platforms.
AMEX
LODE
Comstock INCComstock Inc. reported a reduced net loss for 2025, driven by significant capital raises and strategic advancements in its solar panel recycling and renewable fuels segments, despite a decline in overall revenue.
NASDAQ
Fractyl Health, a clinical-stage metabolic therapeutics company, reported significant net losses and raised substantial doubt about its ability to continue as a going concern, despite advancing its Revita and Rejuva product candidates.
NASDAQ
NGNE
Neurogene INCNeurogene Inc. reported a widened net loss for 2025 while making significant clinical and regulatory progress with its lead gene therapy candidate, NGN-401, for Rett syndrome.
NYSE
GameStop reports a significant increase in net income for fiscal 2025, driven by strategic capital allocation, cost optimization, and growth in collectibles, despite a decline in overall net sales.
AMEX
Chicago Rivet & Machine Co. reported recurring operating losses and liquidity reduction for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, despite some revenue growth and efficiency gains.
NYSE
SCE Recovery Funding LLC and its servicers confirm material compliance with SEC Regulation AB servicing criteria for asset-backed securities for the fiscal year ended December 31, 2025.
OQB
Circle Energy, an exploration-stage oil and gas company, reported an increased net loss for 2025 and continues to seek capital to fund its undeveloped Permian Basin acreage.
NASDAQ
VenHub Global, Inc. reported a net loss of over $62 million in 2025, a significant increase from the prior year, as it navigates early commercialization and seeks additional capital.
OQX
CreditRiskMonitor.com reported a 2% revenue increase to $20.1 million in 2025, but net income declined by 39% to $1.0 million, alongside strategic management changes and continued product development.
NASDAQ
Perma-Fix Environmental Services reports modest 2025 revenue growth driven by its Treatment Segment and advances in PFAS destruction technology, despite a net loss and Services Segment decline.
OQX
TBTC
Table Trac INCTable Trac, Inc. reported a slight decrease in total revenue for fiscal year 2025, driven by lower system sales, but saw an increase in net income and a significant boost in cash and cash equivalents.
NASDAQ
Silver Pegasus Acquisition Corp. (SPAC) files its 2025 annual report, outlining its blank check operations, share structure, and significant risks related to its business combination deadline and potential dilution.